FDA announces shortages of Tamiflu oral suspension
The US Food and Drug Administration (FDA) announced on Monday that the manufacturer of Oseltamivir Phosphate (Tamiflu) Oral Suspension, Genentech, Inc., is experiencing temporary delays in manufacturing of More...
DOD announces the first patient enrolled for Phase 3 clinical trials for broad spectrum flu drug, Favipiravir
BioDefense Therapeutics (BD Tx)—a Joint Product Management office within the U.S. Department of Defense (DoD)—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir More...
Tamiflu approved to treat children as young as 2 weeks old: FDA
Public domain image/Moriori at the English Wikipedia project (cropped) The U.S. Food and Drug Administration (FDA) today expanded the approved use of Tamiflu (oseltamivir) to treat children as young as 2 weeks old More...